This clinical trial tests a multilevel intervention at the clinic, provider and patient levels, to improve colonoscopy surveillance in patients with high risk colon polyps. Colorectal cancer (CRC) is a common and deadly disease that is largely preventable through the detection and removal of colorectal polyps. One million Americans are diagnosed with high risk polyps of the colon or rectum annually and are at increased risk for CRC; however, uptake of recommended repeat colonoscopy in 3 years to reduce CRC risk is low in this group. This multilevel intervention may work to improve timely colonoscopy screening for patients with high risk colon polyps.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Stakeholder perspectives on the multilevel intervention (Aim 1)
Timeframe: At time of interview
Completion of surveillance colonoscopy (Aim 2)
Timeframe: At 3.5 years
Implementation quality (Aim 3a)
Timeframe: Up to 3 years
Cost effectiveness (Aim 3b)
Timeframe: Up to 3 years